An engineered superantigen SEC2 exhibits promising antitumor activity and low toxicity - Xu, Mingkai; Wang, Xiaogang; Cai, Yongming; Zhang, Huiwen; Yang, Hongli; Liu, Changxiao; Zhang, Chenggang (Cancer Immunology, Immunotherapy, 2011)
Keywords: Animals; Antigens; Antineoplastic agents; Antineoplastic Agents - chemistry; Antineoplastic Agents - immunology; Antineoplastic Agents - toxicity; Bacterial diseases; Biological and medical sciences; Cancer; Cancer Research; Cell Line, Tumor; E coli; Enterotoxins - chemistry; Enterotoxins - genetics; Enterotoxins - immunology; Enterotoxins - toxicity; Enzymes; Female; Human bacterial diseases; Immunology; Immunotherapy; Infectious diseases; Laboratory animals; Medical sciences; Medicine; Medicine & Public Health; Mice; Mice, Inbred BALB C; Mutagenesis; Mutagenesis, Site-Directed; Mutation; Neoplasms - therapy; Oncology; Original; Original Article; Pets; Pharmacology. Drug treatments; Plasmids; Point Mutation; Protein Engineering; Rabbits; Staphylococcal infections, streptococcal infections, pneumococcal infections; Superantigens - genetics; Superantigens - immunology; Superantigens - toxicity; Toxicity; China; Superantigen; Site-directed mutagenesis; Immunotherapy; Staphylococcal enterotoxin C2; Antineoplastic agent; Toxicity; Site directed mutagenesis; Biological activity; Staphylococcus; Infection; Toxin; Treatment; Bacteriosis; Enterotoxin; Bacteria; Micrococcales; Micrococcaceae; Staphylococcal infection